Aster DM Q2 PAT rises 34% to ₹281 crore, revenue up 19%

SENSEX 81,028.02

+ 1,718.01

NIFTY 25,030.35

+ 493.75

CRUDEOIL 8,512.00

 -48.00

GOLD 141,931.00

 -2,164.00

SILVER 185,436.00

 -1,704.00

SENSEX 81,028.02

+ 1,718.01

NIFTY 25,030.35

+ 493.75

NIFTY 25,030.35

+ 493.75

CRUDEOIL 8,512.00

 -48.00

CRUDEOIL 8,512.00

 -48.00

GOLD 141,931.00

 -2,164.00

'; } document.getElementById("lgdv").innerHTML = htmlElements; } function numberformat(i) { return Number(parseFloat(i).toFixed(2)).toLocaleString('en', { minimumFractionDigits: 2 }) } async function gatherResponse(response) { const { headers } = response; const contentType = headers.get('content-type') || ''; if (contentType.includes('application/json')) { return await response.json() } return response.text(); } function getWidth() { if (Math.max(document.body.scrollWidth,document.documentElement.scrollWidth,document.body.offsetWidth,document.documentElement.offsetWidth,document.documentElement.clientWidth) > 991) { document.getElementById("mob").style.display = "none"; document.getElementById("lgdv").style.display = "block"; } else { document.getElementById("mob").style.display = "block"; document.getElementById("lgdv").style.display = "none"; } } getWidth(); THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.

Revenue from operations rose 19% year-on-year to ₹2,829 crore

By BL Bengaluru Bureau

Updated - November 06, 2026 at 09:06 PM.

Healthcare provider Aster DM Healthcare posted a 34 per cent year-on-year increase in normalised profit after tax (PAT) to ₹281 crore in the second quarter of FY27.

Revenue from operations rose 19 per cent year-on-year to ₹2,829 crore.

The quarter marked the first reporting period for the company as a combined entity. Total patient volumes grew 12 per cent year-on-year, led by the Neurosciences, Oncology, Orthopaedics and Gastroenterology segments.

Occupancy improved by 335 basis points to 68 per cent, from 65 per cent in the corresponding quarter last year, driven by growth in patient volumes across key specialties and an increase in medical value travel (MVT) patient flows.

MVT revenue grew 36 per cent year-on-year, led by patients from the Maldives and GCC markets, with rising contributions from West Africa and other MENA countries.

Commenting on the results, Dr Azad Moopen, Executive Chairman, said the company had delivered a strong performance in Q2 FY27, with revenue growing 19 per cent to ₹2,829 crore and normalised PAT increasing 34 per cent to ₹281 crore. The emerging hospitals portfolio, including Kasargod and Nagercoil, recorded 61 per cent growth, highlighting the increasing contribution of these units.

In the first half of FY27, mature hospitals contributed approximately 73 per cent of hospital revenue, registering 18 per cent year-on-year growth, driven by steady patient volume growth and an increasing share of complex clinical cases.

Emerging hospitals, including Kasargod and Nagercoil, recorded 62 per cent year-on-year growth, supported by higher inpatient and outpatient volumes.

Published on November 6, 2026

THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.Sign into Unlock benefits!

• Access 10 free stories per month
• Get notified by email for early preview to new features, discounts & offers